VBI Vaccines (Nasdaq: VBIV) (“VBI”) is scheduled to present at the Noble Financial Emerging Growth Investor Conference on Monday, January 18th, 2016 at 10:00 AM ET. The event is being held at the Club Med in Sandpiper Bay, FL.
During the presentation, Nell Beattie, VBI’s Director, Corporate Development and Investor Relations, will provide an overview of VBI and its platform technologies, and will summarize recent developments in the company’s pipeline of vaccine candidates. Ms. Beattie will also discuss VBI’s planned merger with SciVac Therapeutics (TSX:VAC and OTCQX:SVACF) (“SciVac”), including SciVac’s flagship product, Sci-B-Vac®, a commercial hepatitis B (“HBV”) vaccine.For additional information, or to schedule a one-on-one meeting with VBI management, please contact firstname.lastname@example.org.
- Event: Twelfth Annual Noble Financial Emerging Growth Investor Conference
- Date: Monday, January 18th, 2016
- Time: 10:00 AM ET
- Location: Club Med in Sandpiper Bay, FL
- Event Website: http://bit.ly/noblecon-2016